| Age |
1 Dose (%) |
2 Doses (%) |
3 Doses (%) |
|
| 18 |
9 |
1.9 (0.7-3.1) |
5 |
1.1 (0.1-2.0) |
0 |
|
| 19 |
18 |
3.8 (2.1-5.5) |
7 |
1.5 (0.4-2.6) |
13 |
7.3 (3.5-11.2) |
| 20 |
18 |
3.8 (2.1-5.5) |
17 |
3.6 (1.9-5.3) |
22 |
12.4 (7.6-17.3) |
| 21 |
22 |
4.7 (2.8-6.6) |
15 |
3.2 (1.6-4.8) |
30 |
16.9 (11.4-22.5) |
| 22 |
23 |
4.9 (2.9-6.8) |
8 |
1.7 (0.5-2.9) |
25 |
14.1 (9.0-19.3) |
| 23 |
21 |
4.4 (2.6-6.3) |
20 |
4.2 (2.4-6.1) |
26 |
14.7 (9.5-19.9) |
| 24 |
24 |
5.1 (3.1-7.1) |
17 |
3.6 (1.9-5.3) |
22 |
12.4 (7.6-17.3) |
| 25 |
23 |
4.9 (2.9-6.8) |
25 |
5.3 (3.3-7.3) |
26 |
14.7 (9.5-19.9) |
| ≥26* |
16 |
3.4 (1.8-5.0) |
7 |
1.5 (0.4-2.6) |
13 |
7.3 (3.5-11.2) |
| Total |
174 |
|
121 |
|
177 |
|
*Includes females who were older than 26 when they received 2nd or 3rd injection |
